A carregar...
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer
RET receptor tyrosine kinase (RTK) acts as an ontogenetic driver in several human malignancies, including papillary and medullary thyroid carcinoma, lung adenocarcinoma, colorectal carcinoma, Spitzoid neoplasms, salivary gland carcinoma and chronic myeloproliferative disorders, secondary to as diver...
Na minha lista:
| Publicado no: | Best Pract Res Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624797/ https://ncbi.nlm.nih.gov/pubmed/28911727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beem.2017.04.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|